Form Bio

Form Bio is a computational life sciences company based in Austin, Texas, focused on advancing genetic medicine, genome engineering, and drug discovery for cell and gene therapies.

Founded in 2022 as the first spinout from Colossal Biosciences, the company offers AI-powered software platforms that streamline scientific workflows. Their user-friendly tools allow scientists to design experiments, conduct AI-driven analyses, visualize results, and collaborate securely. The company's key offerings include FORM'sight AI for predictive modeling in drug development, a cloud-based bioinformatics platform for data management and analysis, and in silico assays for evaluating therapeutic vector designs. Form Bio specializes in optimizing adeno-associated virus (AAV) vectors and enhancing CRISPR accuracy, which supports researchers in reducing time, cost, and risk during preclinical development. They primarily serve professionals in cell and gene therapy, biomanufacturing, and academic research, helping organizations advance therapeutic designs from initial concepts to regulatory submission.